Skin Cancer (non-melanoma) SACT consent forms – CRUK

We are pleased to inform you that the Skin Cancer (non-melanoma) SACT consent forms have been reviewed and updated. They are now available on the CRUK website at : www.cruk.org/sact_consent.

A couple of new regimens have been added to the list

  1. Cemiplimab
  2. Vismodegib

Please note that the regimens with cutaneous lymphoma indications have not been updated. They will be reviewed and updated alongside the Lymphoma group which is in progress.

Please share this update within your clinical teams or forward to the relevant lead cancer clinician for your organisation.

Any questions, please do let me know.

Best wishes,

Alia

Alia Nizam |Specialist Oncology Pharmacist. CRUK – Information Lead|

Latest News

By BOPA Executive Committee on 24th August 2026

BOPA 2026 Executive Committee Election – Have you cast your vote for your candidates?

Have you cast your vote for the 2026 BOPA Executive Committee Election? In 2026 we received 9 nominations for 6 positions. -Standard Committee Member (6 places available) – VOTING FOR…

Read article
By BOPA Committee on 12th August 2026

The British Colorectal Oncology Group (BCOG) Annual Conference 2026 – Register NOW

The British Colorectal Oncology Group warmly invites you to its inaugural annual conference at the Queen’s Hotel, Leeds Find the conference agenda here – BCOG-Annual-Conference-Programme-2026.pdf Register NOW – British Colorectal…

Read article
By BOPA Executive Committee on 10th August 2026

Highlights of CAPhO Conference 2026 Webinar

Participants are invited to participate in the Highlights of CAPhO Conference 2026 Webinar hosted by the Canadian Association of Pharmacy in Oncology (CAPhO). Taking place on Wednesday, August 19, 2026 at 08:00 PT,…

Read article
By BOPA Executive Committee on 10th August 2026

BOPA 2026 Executive Committee Election – Its time to cast your vote!

Thank you to all of our nominees this year – we really appreciate your nominations for the Executive Committee.  Summary of nominations: In 2026 we received 9 nominations for 6…

Read article